Business Context and Reporting Period
Research Frontiers Incorporated filed a Form 10-K for the fiscal year ended December 31, 2022. The company operates in one segment, developing and licensing suspended particle device (SPD-Smart) light-control technology for automotive, aerospace, architectural, marine, transportation, display and related applications. It does not directly manufacture products and depends on more than 40 licensees and their customers for commercialization and royalty revenue.
The filing was signed March 9, 2023. The company had 33,150,396 shares outstanding at December 31, 2022 and 33,509,287 shares outstanding on March 9, 2023.
Key Financial Metrics
| Metric | 2022 | 2021 |
|---|---|---|
| Fee income | $539,686 | $1,263,034 |
| Total operating expenses | $3,164,816 | $3,101,849 |
| Operating loss | $2,625,130 | $1,838,815 |
| Net investment loss | $44,219 | $7,537 |
| Net loss | $2,669,349 | $1,846,352 |
| Basic and diluted loss per share | $0.08 loss | $0.06 loss |
| Net cash used in operating activities | $2,182,745 | $1,804,293 |
| Cash and cash equivalents at year-end | $4,230,916 | $269,964 |
| Working capital | Approximately $4.6 million | Approximately $3.7 million |
| Total shareholders’ equity | $4,796,865 | $3,783,923 |
The filing’s MD&A refers to 2022 fee income of $536,686, while the audited statement of operations reports $539,686. The filing text does not explain this discrepancy; investors should verify the correct amount against the filed financial statements and XBRL data.
Operating expenses increased modestly, including $2.56 million of operating expenses and $609,127 of research and development costs. Share-based compensation totaled $232,291. No income tax expense or benefit was recorded, and deferred tax assets were fully reserved.
The company had no marketable securities at December 31, 2022, compared with $2.76 million at December 31, 2021. It had no debt, although it had operating lease liabilities with total future payments of $495,000 and a present value of $464,128.
Material Changes Versus the Prior Comparable Period
- Fee income declined approximately 57.3% from 2021, primarily because 2021 included one-time settlements from two licensees and a special government automotive contract. Management stated that excluding those items, 2022 fee income would have been comparable to 2021.
- Net loss increased approximately 44.5%, driven mainly by lower fee income, higher operating and research costs, and a larger investment loss.
- Operating cash use increased approximately 21.0% to $2.18 million.
- Cash increased by approximately $3.96 million, primarily from $3.45 million received through the issuance of common stock and warrants and $2.69 million from sales of marketable securities, partly offset by operating cash use.
- In September 2022, the company agreed to sell 2.0 million shares at $2.30 per share. By year-end, it had received $3.45 million, issued 1.5 million shares and 1.5 million warrants, and expected to receive the remaining $1.15 million in March 2023.
- The company’s licensee Gauzy acquired Vision Systems after Gauzy completed a $60 million Series D financing. The transaction expanded Gauzy’s manufacturing, distribution and geographic capabilities.
- Four licensees represented 28%, 23%, 13% and 11% of 2022 fee income, highlighting increased concentration relative to the prior year’s 20%, 18%, 18% and 12% mix.
Guidance, Outlook, Risks and Unusual Items
Management expects automotive applications to remain the largest source of royalty income and expects additional revenue from new automotive and aircraft models, marine products, trains, museums and architectural projects. The filing does not provide formal revenue or earnings guidance.
Management estimates a quarterly cash-flow shortfall of approximately $200,000 under current operating assumptions and expects existing working capital to fund operations for more than five years, assuming anticipated royalties and expense levels. The financial statement notes use more cautious language, stating that working capital is expected to fund operations for at least 12 months from issuance. Additional equity financing may be required if cash needs increase or royalty commercialization is delayed.
- The company has incurred recurring losses since inception, with an accumulated deficit of $122.4 million at year-end 2022.
- Revenue depends on licensees’ product development, production volumes, customer adoption and royalty payments; the company has not historically generated sufficient license revenue to fund operations.
- Only Hitachi Chemical/Showa Denko and Gauzy were identified as sources of commercial quantities of SPD film. Showa Denko may reduce or discontinue SPD-film sales and branding following its acquisition of Hitachi Chemical.
- Licensee and customer concentration creates material exposure to the loss or financial difficulty of significant licensees.
- Competition includes electrochromic, liquid-crystal and other smart-glass technologies, many backed by substantially larger companies.
- Automotive, aircraft, train, marine and construction downturns could reduce licensee production and royalties.
- COVID-19-related manufacturing and supply-chain disruptions had negatively affected revenue since 2020, and the filing states that future effects cannot be reasonably estimated.
- The company relies on a small workforce, including six full-time employees as of March 9, 2023, and is dependent on key personnel.
- The company extended its stockholder rights plan through February 11, 2033. The plan generally applies when a person or group reaches 15% beneficial ownership, subject to stated exceptions.
- There were no reported legal proceedings, off-balance-sheet arrangements or material environmental capital expenditures. Management concluded that disclosure controls and internal control over financial reporting were effective.
Most Important Facts for Investors to Verify
- Reconcile the $536,686 MD&A fee-income figure with the $539,686 amount in the audited financial statements.
- Verify the timing and receipt of the remaining $1.15 million private-placement proceeds and the related share and warrant issuance.
- Assess whether Gauzy’s acquisition of Vision Systems is translating into increased SPD film production, product launches and royalty revenue.
- Review the concentration and collectability of royalties, including the $1.16 million allowance for doubtful accounts and the largest receivable exposure.
- Evaluate the company’s continuing operating losses, approximately $2.18 million of annual operating cash use and dependence on future royalties or equity financing.
- Monitor the availability of commercial SPD film, including any reduction or discontinuation of Showa Denko supply.
- Confirm the status, production volumes and royalty economics of announced automotive, aircraft, marine, rail and architectural programs.
- Review dilution risk from 1.25 million outstanding employee options and 2.90 million outstanding warrants at December 31, 2022, plus subsequent warrant exercises.